Posts by Mark Darwin
Nvidia CEO tours China during Beijing antitrust probe, AI curbs
NVIDIA chief Jensen Huang is embarking on a trip to China this week, visiting major cities at a time Beijing is investigating his company’s domestic presence and Washington is slapping new curbs on the sale of its artificial intelligence (AI) chips abroad. The Nvidia chief executive officer is due to arrive in Shenzhen for employees’…
Read MoreTech supplier Arm plans to hike prices, has considered developing its own chips
ARM Holdings, a technology supplier to chip firms, is developing a long-term strategy to hike prices by as much as 300 per cent and has discussed designing its own chips in a move to compete with its biggest customers. For decades, the British firm kept a low profile while operating at the heart of billions…
Read MoreRisk of TikTok ban has users rushing to download two other Chinese-made apps
A PAIR of Chinese-made social apps, Xiaohongshu and Lemon8, have taken over the top two positions on Apple’s iPhone download charts in the US as users seek out alternatives to TikTok ahead of an imminent ban. ByteDance’s TikTok faces a deadline of Jan 19 to find a US buyer in order to continue operating in…
Read MoreChina discusses sale of TikTok US to Elon Musk as one possible option
CHINESE officials are evaluating a potential option that involves Elon Musk acquiring the US operations of TikTok if the company fails to fend off a controversial ban on the short-video app, according to sources familiar with the matter. Beijing officials strongly prefer that TikTok remains under the ownership of parent ByteDance, the sources say, and…
Read MoreRobinhood to pay US$45 million to settle SEC charges over record keeping, other violations
ONLINE trading firm Robinhood Markets has agreed to pay US$45 million to settle US Securities and Exchange Commission (SEC) charges over record keeping, trade reporting and other rule violations, the regulator said on Monday (Jan 13). Regulators found Robinhood Securities and Robinhood Financial violated numerous requirements such as accurately reporting trading activity; filing timely reports…
Read MoreBiggest US banks ready mortgage relief for victims of Los Angeles wildfires
JPMORGAN Chase and Bank of America (BOA) are easing mortgage repayment conditions for customers affected by the Los Angeles wildfires, as residents grapple with one of the most destructive natural disasters in the city’s history. Chase Home Lending is providing disaster forbearance for mortgage customers affected by the wildfires, parent firm JPMorgan said on Monday…
Read MoreUS: Wall St opens lower as investors dial back bets on Fed rate cuts this year
Wall Street’s main indexes opened lower on Monday (Jan 13), as yields surged after robust payroll numbers last week bolstered expectations that the Federal Reserve will maintain a hawkish stance for most of 2025. The Dow Jones Industrial Average fell 13.8 points, or 0.03 per cent, at the open to 41,924.68. The S&P 500 fell…
Read MoreGold beats STI, Hong Kong-listed tech to be top-traded ETF on SGX in 2024
The precious metal continues to shine as investors look to diversify equity and bond portfolios amid geopolitical tensions and market volatility, says analyst RECORD-HIGH gold prices in 2024 have fuelled investment appetite for physically backed gold exchange-traded funds (ETFs) in Singapore. SPDR Gold Shares, the only gold ETF on the Singapore Exchange (SGX), was the…
Read MoreSunday Mail Mystery Solved: Here’s When USPS Actually Delivers
Ever found yourself puzzled about whether your mail will show up on a Sunday? You’re not alone. Many folks are curious about how USPS handles Sunday deliveries. While it’s not the norm for mail to arrive on this day, there are exceptions. Let’s unravel the mystery of Sunday mail, so you know exactly what to…
Read MoreGSK to buy US cancer biotech IDRx for up to US$1.15 billion
GSK agreed to buy US biotech IDRx for as much as US$1.15 billion to gain new cancer medicines. The UK drugmaker will pay US$1 billion upfront for IDRx, whose lead drug for gastrointestinal tumours shows potential against mutations that currently leave patients with few treatment options, GSK said on Monday (Jan 13). IDRx’s experimental medicine…
Read More